Cantor Fitzgerald Europe lowers stake in SymBio Pharmaceuticals to 9.26%
Stake history
Summary
Cantor Fitzgerald Europe filed a Change in 5%+ stake (change report) via EDINET on 2026-03-02 13:03 JST concerning SymBio Pharmaceuticals Limited. Reported holding ratio: 9.26%, previous report: 13.68%.